You are here

  • Home
  • Archive
  • Volume 82, Issue 4
  • Response to: ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Yang et al

Article Text

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Yang et al
  1. Shintaro Akiyama1,
  2. Shadi Hamdeh2,
  3. Dejan Micic1,
  4. Atsushi Sakuraba1
  1. 1 Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA
  2. 2 Department of Internal Medicine, Division of Gastroenterology, Hepatology and Motility, University of Kansas, Kansas City, Kansas, USA
  1. Correspondence to Dr Atsushi Sakuraba, Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Il 60637, USA; asakurab{at}medicine.bsd.uchicago.edu

https://doi.org/10.1136/annrheumdis-2021-219855

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Yang et al 1 for their comments with an updated meta-analysis to our research article ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’.2 Their findings contribute to accurate elaboration and substantiation of our findings.

    Yang et al 1 undertook an updated meta-analysis, including studies that were reported after our article was published, and found that patients with autoimmune diseases had a significantly increased risk of mortality compared with those without. This is in contrast to our results which showed no such increased risk. This difference is likely due to the larger number of publications and patients included in their updated meta-analysis. Indeed, there are a growing number of …

    View Full Text

    Footnotes

    • Handling editor Josef S Smolen

    • Correction notice This article has been corrected since it published Online First. The provenance and peer review statement has been included.

    • Contributors Drafting of the manuscript: SA, SH, DM and AS. Critical review of the manuscript: SA and AS.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles